{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:33:28Z","timestamp":1792082008453,"version":"4.4.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"NIH\/NIDCR"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Rheumatoid arthritis (RA), an autoimmune inflammatory disorder, results in persistent synovitis with severe bone and cartilage destruction. Bisphosphonates (BPs) are often utilized in RA patients to reduce bone destruction and manage osteoporosis. However, BPs, especially at high doses, are associated with osteonecrosis of the jaw (ONJ). Here, utilizing previously published ONJ animal models, we are exploring interactions between RA and ONJ incidence and severity. DBA1\/J mice were divided into four groups: control, zoledronic acid (ZA), collagen-induced arthritis (CIA), and CIA-ZA. Animals were pretreated with vehicle or ZA. Bovine collagen II emulsified in Freund's adjuvant was injected to induce arthritis (CIA) and the mandibular molar crowns were drilled to induce periapical disease. Vehicle or ZA treatment continued for 8 weeks. ONJ indices were measured by micro-CT (\u00b5CT) and histological examination of maxillae and mandibles. Arthritis development was assessed by visual scoring of paw swelling, and by \u00b5CT and histology of interphalangeal and knee joints. Maxillae and mandibles of control and CIA mice showed bone loss, periodontal ligament (PDL) space widening, lamina dura loss, and cortex thinning. ZA prevented these changes in both ZA and CIA-ZA groups. Epithelial to alveolar crest distance was increased in the control and CIA mice. This distance was preserved in ZA and CIA-ZA animals. Empty osteocytic lacunae and areas of osteonecrosis were present in ZA and CIA-ZA but more extensively in CIA-ZA animals, indicating more severe ONJ. CIA and CIA-ZA groups developed severe arthritis in the paws and knees. Interphalangeal and knee joints of CIA mice showed advanced bone destruction with cortical erosions and trabecular bone loss, and ZA treatment reduced these effects. Importantly, no osteonecrosis was noted adjacent to areas of articular inflammation in CIA-ZA mice. Our data suggest that ONJ burden was more pronounced in ZA treated CIA mice and that RA could be a risk factor for ONJ development. \u00a9 2016 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2827","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T21:12:48Z","timestamp":1457385168000},"page":"1596-1607","source":"Crossref","is-referenced-by-count":46,"title":["Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study"],"prefix":"10.1093","volume":"31","author":[{"given":"Rafael Scaf","family":"de Molon","sequence":"first","affiliation":[{"name":"Department of Diagnosis and SurgerySchool of Dentistry at Araraquara, Sao Paulo State UniversityAraraquaraBrazil"},{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos AngelesCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chingyun","family":"Hsu","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos AngelesCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Bezouglaia","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos AngelesCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Dry","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory MedicineDavid Geffen School of Medicine at UCLALos AngelesCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Q","family":"Pirih","sequence":"additional","affiliation":[{"name":"Division of Constitutive & Regenerative SciencesUCLA School of DentistryLos AngelesCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akrivoula","family":"Soundia","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos AngelesCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Queiroz","family":"Cunha","sequence":"additional","affiliation":[{"name":"Department of PharmacologySchool of Medicine of Ribeirao PretoSao PauloBrazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni Augusto","family":"Cirelli","sequence":"additional","affiliation":[{"name":"Department of Diagnosis and SurgerySchool of Dentistry at Araraquara, Sao Paulo State UniversityAraraquaraBrazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara L","family":"Aghaloo","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos AngelesCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[{"name":"Molecular Biology InstituteUCLALos AngelesCAUSA"},{"name":"Division of Diagnostic and Surgical SciencesUCLA School of DentistryLos AngelesCAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"2024021014184341400_jbmr2827-bib-0001","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"2024021014184341400_jbmr2827-bib-0002","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"2024021014184341400_jbmr2827-bib-0003","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"2024021014184341400_jbmr2827-bib-0004","first-page":"1282","article-title":"Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis","volume":"25","author":"Gough","year":"1998","journal-title":"J Rheumatol"},{"key":"2024021014184341400_jbmr2827-bib-0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jb\/mvv069","article-title":"Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside","volume":"158","author":"Tanaka","year":"2015","journal-title":"J Biochem"},{"key":"2024021014184341400_jbmr2827-bib-0006","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/0470846658.ch17","article-title":"Clinical disorders of bone resorption","volume":"232","author":"Russell","year":"2001","journal-title":"Novartis Found Symp"},{"key":"2024021014184341400_jbmr2827-bib-0007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11914-013-0172-1","article-title":"Osteoporosis and osteoarthritis, rheumatoid arthritis and spondylarthropathies","volume":"11","author":"Clayton","year":"2013","journal-title":"Curr Osteoporos Rep"},{"key":"2024021014184341400_jbmr2827-bib-0008","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3899\/jrheum.120810","article-title":"Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis","volume":"40","author":"Lescaille","year":"2013","journal-title":"J Rheumatol"},{"key":"2024021014184341400_jbmr2827-bib-0009","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1756-185X.2012.01729.x","article-title":"Increased frequency of osteoporosis and BMD below the expected range for age among South Korean women with rheumatoid arthritis","volume":"15","author":"Lee","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"2024021014184341400_jbmr2827-bib-0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/CIA.S2134","article-title":"Bisphosphonates in the management of postmenopausal osteoporosis\u2015optimizing efficacy in clinical practice","volume":"3","author":"Bock","year":"2008","journal-title":"Clin Interv Aging"},{"key":"2024021014184341400_jbmr2827-bib-0011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.med.50.1.237","article-title":"Bisphosphonates in the treatment of malignant bone disease","volume":"50","author":"Berenson","year":"1999","journal-title":"Annu Rev Med"},{"key":"2024021014184341400_jbmr2827-bib-0012","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"2024021014184341400_jbmr2827-bib-0013","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00198-005-1945-x","article-title":"Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies","volume":"16","author":"Boonen","year":"2005","journal-title":"Osteoporos Int"},{"key":"2024021014184341400_jbmr2827-bib-0014","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"2024021014184341400_jbmr2827-bib-0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1746-160X-8-5","article-title":"Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws","volume":"8","author":"Conte-Neto","year":"2012","journal-title":"Head Face Med"},{"key":"2024021014184341400_jbmr2827-bib-0016","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","author":"Adler","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2024021014184341400_jbmr2827-bib-0017","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"2024021014184341400_jbmr2827-bib-0018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2024021014184341400_jbmr2827-bib-0019","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2024021014184341400_jbmr2827-bib-0020","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"2024021014184341400_jbmr2827-bib-0021","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20152014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"2024021014184341400_jbmr2827-bib-0022","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of osteonecrosis of the jaws","volume":"27","author":"Aghaloo","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"2024021014184341400_jbmr2827-bib-0023","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","article-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data","volume":"67","author":"Allen","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"2024021014184341400_jbmr2827-bib-0024","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.11607\/jomi.te41","article-title":"A review of pharmaceutical agents and oral bone health: how osteonecrosis of the jaw has affected the field","volume":"29","author":"Allen","year":"2014","journal-title":"Int J Oral Maxillofac Implants"},{"key":"2024021014184341400_jbmr2827-bib-0025","article-title":"Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015","author":"Khan","year":"2015","journal-title":"Osteoporos Int"},{"key":"2024021014184341400_jbmr2827-bib-0026","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2577","article-title":"Bisphosphonate induces osteonecrosis of the jaw in diabetic mice via NLRP3\/Caspase-1-Dependent IL-1beta mechanism","author":"Zhang","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2024021014184341400_jbmr2827-bib-0027","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1746-160X-7-7","article-title":"Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports","volume":"7","author":"Conte-Neto","year":"2011","journal-title":"Head Face Med"},{"key":"2024021014184341400_jbmr2827-bib-0028","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3899\/jrheum.130440","article-title":"Osteonecrosis of the jaw and rheumatoid arthritis. Is it the disease or the drugs","volume":"40","author":"Landesberg","year":"2013","journal-title":"J Rheumatol"},{"key":"2024021014184341400_jbmr2827-bib-0029","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00198-009-0973-3","article-title":"Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases","volume":"21","author":"Park","year":"2010","journal-title":"Osteoporos Int"},{"key":"2024021014184341400_jbmr2827-bib-0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbmr.2097","article-title":"RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease","volume":"29","author":"Aghaloo","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2024021014184341400_jbmr2827-bib-0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2014.07.027","article-title":"Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model","volume":"68","author":"de Molon","year":"2014","journal-title":"Bone"},{"key":"2024021014184341400_jbmr2827-bib-0032","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.2490","article-title":"OPG-Fc but not zoledronic acid discontinuation reverses osteonecrosis of the jaws (ONJ) in mice","volume":"30","author":"de Molon","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2024021014184341400_jbmr2827-bib-0033","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jbmr.1894","article-title":"Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice","volume":"28","author":"Kang","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2024021014184341400_jbmr2827-bib-0034","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.joca.2012.02.010","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"20","author":"Kilkenny","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"2024021014184341400_jbmr2827-bib-0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1258\/002367778780936296","article-title":"The occurrence in mice of facial and mandibular abscesses associated with Staphylococcus aureus","volume":"12","author":"Clarke","year":"1978","journal-title":"Lab Anim"},{"key":"2024021014184341400_jbmr2827-bib-0036","first-page":"25","article-title":"Mandibular mass in a young Swiss-Webster mouse","volume":"31","author":"Grant","year":"2002","journal-title":"Lab Anim (NY)"},{"key":"2024021014184341400_jbmr2827-bib-0037","first-page":"200","article-title":"Etiopathogenesis of mandibulofacial and maxillofacial abscesses in mice","volume":"60","author":"Lawson","year":"2010","journal-title":"Comp Med"},{"key":"2024021014184341400_jbmr2827-bib-0038","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat Protoc"},{"key":"2024021014184341400_jbmr2827-bib-0039","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"key":"2024021014184341400_jbmr2827-bib-0040","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/art.21827","article-title":"Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis","volume":"54","author":"Coppieters","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2024021014184341400_jbmr2827-bib-0041","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.4049\/jimmunol.1301970","article-title":"Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response","volume":"192","author":"de Aquino","year":"2014","journal-title":"J Immunol"},{"key":"2024021014184341400_jbmr2827-bib-0042","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/art.38312","article-title":"Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritis","volume":"66","author":"Marijnissen","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2024021014184341400_jbmr2827-bib-0043","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.mehy.2011.08.008","article-title":"Is rheumatoid arthritis a risk factor for oral bisphosphonate-induced osteonecrosis of the jaws","volume":"77","author":"Conte Neto","year":"2011","journal-title":"Med Hypotheses"},{"key":"2024021014184341400_jbmr2827-bib-0044","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jicd.12018","article-title":"Host responses induced by different animal models of periodontal disease: a literature review","volume":"4","author":"de Molon","year":"2013","journal-title":"J Investig Clin Dent"},{"key":"2024021014184341400_jbmr2827-bib-0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1902\/jop.2013.130225","article-title":"Evaluation of the host response in various models of induced periodontal disease in mice","volume":"85","author":"de Molon","year":"2014","journal-title":"J Periodontol"},{"key":"2024021014184341400_jbmr2827-bib-0046","article-title":"Long-term evaluation of oral gavage with periodontopathogens or ligature induction of experimental periodontal disease in mice","author":"de Molon","year":"2015","journal-title":"Clin Oral Investig. Epub"},{"issue":"e9\u2013","key":"2024021014184341400_jbmr2827-bib-0047","first-page":"e17","article-title":"Obesity and hyperlipidemia modulate alveolar bone loss in Wistar rats","volume":"87","author":"Cavagni","year":"2016","journal-title":"J Periodontol"},{"key":"2024021014184341400_jbmr2827-bib-0048","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.20158","article-title":"Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983\u20132001","volume":"50","author":"Ward","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2024021014184341400_jbmr2827-bib-0049","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/ard.2005.049338","article-title":"Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment","volume":"65","author":"Finckh","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2024021014184341400_jbmr2827-bib-0050","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.20382","article-title":"Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis","volume":"50","author":"Sims","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2024021014184341400_jbmr2827-bib-0051","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/art.21841","article-title":"Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis","volume":"55","author":"Giles","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2024021014184341400_jbmr2827-bib-0052","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5435\/00124635-200609000-00004","article-title":"Perioperative medication management for the patient with rheumatoid arthritis","volume":"14","author":"Howe","year":"2006","journal-title":"J Am Acad Orthop Surg"},{"key":"2024021014184341400_jbmr2827-bib-0053","first-page":"2695","article-title":"Bone non-union after osteotomy in patients treated with methotrexate","volume":"26","author":"Gerster","year":"1999","journal-title":"J Rheumatol"},{"key":"2024021014184341400_jbmr2827-bib-0054","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S8756-3282(01)00610-X","article-title":"Molecular mechanisms of glucocorticoid-induced osteoporosis","volume":"29","author":"Patschan","year":"2001","journal-title":"Bone"},{"key":"2024021014184341400_jbmr2827-bib-0055","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0903036","article-title":"Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells","volume":"362","author":"Greenberger","year":"2010","journal-title":"N Engl J Med"},{"key":"2024021014184341400_jbmr2827-bib-0056","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0002-9343(85)90057-9","article-title":"Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus","volume":"79","author":"Zizic","year":"1985","journal-title":"Am J Med"},{"key":"2024021014184341400_jbmr2827-bib-0057","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.oraloncology.2008.04.013","article-title":"Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral Oncol"},{"key":"2024021014184341400_jbmr2827-bib-0058","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology"},{"key":"2024021014184341400_jbmr2827-bib-0059","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2024021014184341400_jbmr2827-bib-0060","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.joms.2014.07.004","article-title":"Bisphosphonate uptake in areas of tooth extraction or periapical disease","volume":"72","author":"Cheong","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"2024021014184341400_jbmr2827-bib-0061","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","article-title":"Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis","volume":"30","author":"Romas","year":"2002","journal-title":"Bone"},{"key":"2024021014184341400_jbmr2827-bib-0062","first-page":"1229","article-title":"Articular damage is associated with intraosseous inflammation in the subchondral bone marrow of joints affected by experimental inflammatory arthritis and is modified by zoledronate treatment","volume":"34","author":"Bogoch","year":"2007","journal-title":"J Rheumatol"},{"key":"2024021014184341400_jbmr2827-bib-0063","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/art.10097","article-title":"Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin","volume":"46","author":"Redlich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2024021014184341400_jbmr2827-bib-0064","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"94","author":"Katsarelis","year":"2015","journal-title":"J Dent Res"},{"key":"2024021014184341400_jbmr2827-bib-0065","first-page":"2394","article-title":"Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases","volume":"9","author":"Ibrahim","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2024021014184341400_jbmr2827-bib-0066","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Maerevoet","year":"2005","journal-title":"N Engl J Med"},{"key":"2024021014184341400_jbmr2827-bib-0067","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"},{"key":"2024021014184341400_jbmr2827-bib-0068","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"2024021014184341400_jbmr2827-bib-0069","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","article-title":"Bisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignancies","volume":"112","author":"Fehm","year":"2009","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2827","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2827","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/8\/1596\/56652368\/jbmr2827.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/31\/8\/1596\/56652368\/jbmr2827.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:56:04Z","timestamp":1710341764000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/31\/8\/1596-1607\/7605579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,3,7]]},"published-print":{"date-parts":[[2016,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2827","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,8,1]]},"published":{"date-parts":[[2016,3,7]]}}}